Anhui Fengyuan Pharmaceutical operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Fengyuan Pharmaceutical with three other
companies in this sector in China:
Shanghai Shenqi Pharmaceutical Investment Management CoLtd
sales of 1.59 billion Chinese Renmimbi [US$235.40 million]
of which 100%
Guangdong Zhongsheng Pharmaceutical Co Ltd
(1.58 billion Chinese Renmimbi [US$233.14 million]
of which 96%
was Medicine Manufacture), and
Xiangxue Pharmaceutical Co Ltd
(1.46 billion Chinese Renmimbi [US$216.29 million]
of which 53%
was Pharmaceutical Manufacturing).
During the year ended December of 2015, sales at
Anhui Fengyuan Pharmaceutical were 1.55 billion Chinese Renmimbi (US$229.62 million).
decrease of 8.5%
versus 2014, when the company's sales were 1.70 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 20.9% decline
in Medicine Manufacturing, from 752.97 million Chinese Renmimbi to 595.51 million Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Medicine Retail Circulation (up 0.3% to 920.20 million Chinese Renmimbi)
Other Operations (up 33.7% to 38.58 million Chinese Renmimbi)